Cell-based detection of apf through its interaction with ckap4 for diagnosis of interstitial cystitis

a technology of interstitial cystitis and cell-based detection, which is applied in the field of assay system, can solve the problems of affecting the quality of life of patients, unable to explain why, and most surgeons are reluctant to operate, and achieve the effect of reducing the binding level of ap

Active Publication Date: 2011-10-06
THE COMMONWEALTH MEDICAL COLLEGE +1
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patent describes methods for diagnosing diseases associated with changes in proteins called ATF1 and BCR. These techniques involve analyzing the presence of these substances on a subject's body tissue through Western blot analysis. By detecting changes in the concentration of certain substances in the body, it can identify and treat conditions such as inflammatory disorders caused by abnormal metabolites in the body.

Problems solved by technology

The technical problem addressed in this patent text is the lack of effective therapy for controlling the development of fibrosarcomatute pyramostons (focal bodies) and deaths caused by advanced stage laminariasis, which represent a risk for both childhood and early stages of renal aggraftism.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cell-based  detection of apf through its interaction with ckap4 for diagnosis of interstitial cystitis
  • Cell-based  detection of apf through its interaction with ckap4 for diagnosis of interstitial cystitis
  • Cell-based  detection of apf through its interaction with ckap4 for diagnosis of interstitial cystitis

Examples

Experimental program
Comparison scheme
Effect test

examples

[0297]Example 1. The fluorescent reporter CKAP4-YFP was composed of the following DNA elements: CKAP4 was cloned by reverse transcription from a HeLa cell cDNA library (see FIG. 1). The 5′ primer incorporated a kpnI site and the 3′ primer an XhoI site in order to facilitate cloning. YFP was amplified by PCR from a plasmid containing the coding sequence for YFP. To aid in cloning the 5′ primer for YFP included an XhoI site and the 3′ primer an EcoRI site. The XhoI endonuclease sites, one at the 3′ end of CKAP4 and the other at the 5′ end of YFP resulted in an in-frame fusion of CKAP4 to YFP. Both of these cDNA fragments were ligated into pcDNA3 that was linearized with KpnI and EcoRI. Translation of the mRNA generated from this expression construct began at the start codon of CKAP4 and ended at the stop codon of YPF.

[0298]HeLa cells (ATCC# CCL-2), (SCHERER W F, SYVERTON J T, GEY G O. Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strai

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Timeaaaaaaaaaa
Angleaaaaaaaaaa
Conformationaaaaaaaaaa
Login to view more

Abstract

An assay system designed to detect a protein biomarker in urine that is diagnostic for interstitial cystitis (IC). The presence of a 9 amino acid glycopeptide, antiproliferative factor (APF), in urine is unique to patients with IC. Urine samples from patients who exhibit symptoms consistent with IC are added to the assay system. Binding of APF to the cytoskeletal associated protein 4 (CKAP4) is positive for the presence of APF in urine and diagnostic for IC. The diagnostic system is a significant and surprising advance in diagnosis of IC and has commercial applications relevant to women and men who suffer from symptoms consistent with IC.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner THE COMMONWEALTH MEDICAL COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products